PubMed ·

Endothelial Dysfunction and Inflammatory Pathways in Heart Failure - Role of suPAR and sVCAM-1 as Novel Biomarkers.

Gunanidhi Sakthivel, Vijayakumar Thangavel Mahalingam and Suryaprakash Sabapathi

Published
Source
PubMed
Original
Read it at PubMed
Topics
Cardiology

In brief

Unlocking Heart Failure Insights with New Biomarkers

This paper highlights two emerging biomarkers, suPAR and sVCAM-1, which could provide deeper insights into heart failure's inflammatory and endothelial aspects. Their potential to enhance diagnosis and treatment strategies is a game-changer for managing heart failure.

What they found: The review emphasizes that elevated suPAR and sVCAM-1 levels are significant indicators of inflammation and endothelial dysfunction in heart failure. These biomarkers are associated with increased mortality and rehospitalization rates, particularly in patients with preserved ejection fraction. Their incorporation into clinical practice could enhance risk assessment and support personalized treatment strategies, moving beyond conventional biomarkers.

AI-written summary, not medical advice. Check anything you rely on against the original paper.

From the abstract

Heart failure (HF) is a multifactorial clinical syndrome characterised by myocardial remodelling, endothelial dysfunction, and chronic inflammation.

The opening of the authors’ abstract. The rest is with PubMed.

Read the full abstract at PubMed

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Cardiology

Get the few papers worth your time in Cardiology every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics